CD47 and neoplasm: We further investigated CD47 expression levels in different tumor stages and grades and observed that CD47 is highly expressed in high-grade bladder cancer and muscle-invasive bladder cancer (Figure 1C,D), which suggests that CD47 may be clinically associated with poor prognosis in bladder cancer.